Modernatx, Inc.

This study tested a single shot that aims to protect against both COVID-19 and the flu. About 930 adults aged 50 to 64 received the experimental mRNA-1083 vaccine. Researchers checked for side effects and measured antibody levels one month after vaccination to see how well the im…

This study tested a new mRNA vaccine that targets both influenza and SARS-CoV-2 in a single shot. About 1,758 healthy adults took part to see if the vaccine was safe and triggered a strong immune response. The goal is to simplify annual vaccination by covering two major respirato…

This study tested updated mRNA vaccines (mRNA-1273.214 and mRNA-1273.815) in about 1,800 children aged 6 months to under 6 years. The goal was to see if these vaccines are safe and boost immunity against newer COVID-19 variants. Children received either a first-time vaccine serie…

This study tested an experimental Zika vaccine called mRNA-1893 in 808 healthy adults aged 18 to 65. The goal was to check safety and see how well the vaccine triggers the immune system to fight the Zika virus. Participants received either a low dose, a high dose, or a placebo sh…

This study looked at how long the mRNA-1647 vaccine protects against CMV infection in adults who already completed an earlier vaccine study. A small group also received a booster dose to see if it improves immunity. The goal is to understand the vaccine's long-term safety and imm…

This study tested the Moderna COVID-19 vaccine in over 4,300 healthy adolescents aged 12 to under 18. The goal was to see if the vaccine is safe and works as well in teens as it does in young adults. Participants received either the vaccine or a placebo, and researchers tracked s…

This study tested an experimental mRNA vaccine (mRNA-1345) to protect against RSV, a virus that can cause serious lung infections in older adults. About 3,300 people aged 50 and older received the RSV vaccine alone, with a flu shot, or with a COVID-19 booster. Researchers monitor…

This study tested a new mRNA-based flu vaccine (mRNA-1010) in 172 healthy adults aged 18-50 and 65-80. The goal was to check its safety and how well it boosts the immune system compared to standard flu vaccines. Results help determine if the vaccine is safe and produces a strong …

This study looked at whether a specific mRNA COVID-19 vaccine (mRNA-1273.712) causes a rise in a heart enzyme called troponin, which can signal heart stress. About 1000 healthy volunteers aged 12 to 30 received either the vaccine or a placebo. Researchers measured troponin levels…